ĀÜĄņĀŅĀ×

Michael H. Carrel has served as President and Chief Executive Officer of AtriCure (NASDAQ: ATRC) since November 2012. AtriCure, Inc. is a medical device company that provides innovative solutions for the treatment of atrial fibrillation (Afib) and related conditions. AtriCureā€™s mission is to reduce the global Afib epidemic and heal the lives of those affected.

Since joining AtriCure, Mr. Carrel has fostered a patient-first company approach by focusing on the three core areas: innovation, clinical science, and education. This strategic approach has led AtriCure to significantly invest in groundbreaking clinical trials for the treatment of Afib, left atrial appendage management and pain management; expand its market presence within Europe and Asia; and grow the global employee base from 200 to over 600 employees. In addition, during Mikeā€™s tenure, AtriCure has acquired two companies, Estech and nContact, adding leading ablation technologies to further AtriCureā€™s market position worldwide.

His 24-year career includes successful leadership in global organizations in the healthcare and technology industries. Before joining AtriCure, Mr. Carrel was President and Chief Executive Officer of Vital Images, a publicly-traded medical imaging software company. He led Vital Images to a global leadership position in the healthcare and medical software industry. Under his leadership, the company grew revenue and profitability, increased global market share, expanded its presence to over 90 countries, and lead the company through a sale to Toshiba Medical Systems Corporation. Prior to joining Vital Images, Mike was President and CEO of Zamba Corp., a publicly-traded technology company, and Chief Financial Officer of NextNet Wireless, a privately-held provider of non-line-of-sight plug and play broadband wireless access systems.

Mr. Carrel serves on the Board of Medical Device Manufacturers Association (MDMA) and Axonics Modulation Technologies, Inc. He earned a B.S. in Accounting from Pennsylvania State University and an M.B.A. from the Wharton School at the University of Pennsylvania.